Nkarta Inc [NKTX] stock is trading at $14.63, down -1.68%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The NKTX shares have gain 13.94% over the last week, with a monthly amount glided 44.00%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 28, February 2024, Nkarta to Participate in Upcoming Investor Conferences. In a post published today on Yahoo Finance, Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in three upcoming investor conferences:.
From an analyst’s perspective:
Nkarta Inc [NASDAQ: NKTX] stock has seen the most recent analyst activity on December 22, 2022, when Oppenheimer downgraded its rating to a Perform. Previously, Canaccord Genuity started tracking the stock with Buy rating on October 10, 2022, and set its price target to $25. On July 28, 2022, Needham initiated with a Buy rating and assigned a price target of $26 on the stock. SVB Leerink started tracking the stock assigning a Outperform rating and suggested a price target of $30 on July 18, 2022. Raymond James initiated its recommendation with a Outperform and recommended $17 as its price target on March 11, 2022. H.C. Wainwright started tracking with a Buy rating for this stock on March 08, 2022, and assigned it a price target of $25. In a note dated January 06, 2022, William Blair initiated an Outperform rating.
Nkarta Inc [NKTX] stock has fluctuated between $1.28 and $16.24 over the past year. Currently, Wall Street analysts expect the stock to reach $34 within the next 12 months. Nkarta Inc [NASDAQ: NKTX] shares were valued at $14.63 at the most recent close of the market. An investor can expect a potential return of 132.4% based on the average NKTX price forecast.
Analyzing the NKTX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.3, Equity is -0.37 and Total Capital is -0.36. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.3.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 14.09 points at the first support level, and at 13.54 for the second support level. However, for the 1st resistance point, the stock is sitting at 15.42, and for the 2nd resistance point, it is at 16.20.
Nkarta Inc [NKTX] reported earnings per share of -$0.52 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.67/share, meaning a difference of $0.15 and a surprise factor of 22.40%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.68 per share as compared to estimates of -$0.68 per share, a difference of $0 representing a surprise of 0.00%.
Ratios To Look Out For
For context, Nkarta Inc’s Current Ratio is 10.97. Further, the Quick Ratio stands at 10.97, while the Cash Ratio is 1.49.
Transactions by insiders
Recent insider trading involved Brandenberger Ralph, Chief Technical Officer, that happened on Mar 01 ’24 when 8367.0 shares were sold. Chief Scientific Officer, Trager James completed a deal on Feb 12 ’24 to sell 4143.0 shares. Meanwhile, Chief Executive Officer HASTINGS PAUL J sold 9697.0 shares on Jan 16 ’24.
